Journal Article > CommentaryFull Text
Health Aff (Millwood). 1 September 2015; Volume 34 (Issue 9); 1569-1577.; DOI:10.1377/hlthaff.2015.0375
Kishore SP, Kolappa K, Jarvis JN, Park PH, Belt R, et al.
Health Aff (Millwood). 1 September 2015; Volume 34 (Issue 9); 1569-1577.; DOI:10.1377/hlthaff.2015.0375
The modern access-to-medicines movement grew largely out of the civil-society reaction to the HIV/AIDS pandemic three decades ago. While the movement was successful with regard to HIV/AIDS medications, the increasingly urgent challenge to address access to medicines for noncommunicable diseases has lagged behind-and, in some cases, has been forgotten. In this article we first ask what causes the access gap with respect to lifesaving essential noncommunicable disease medicines and then what can be done to close the gap. Using the example of the push for access to antiretrovirals for HIV/AIDS patients for comparison, we highlight the problems of inadequate global financing and procurement for noncommunicable disease medications, intellectual property barriers and concerns raised by the pharmaceutical industry, and challenges to building stronger civil-society organizations and a patient and humanitarian response from the bottom up to demand treatment. We provide targeted policy recommendations, specific to the public sector, the private sector, and civil society, with the goal of improving access to noncommunicable disease medications globally.
Journal Article > CommentaryAbstract Only
Role of Anesthesiology in Global Health. 19 November 2014; DOI:10.1007/978-3-319-09423-6_9
Trelles M, Kahn P, Cone J, Teicher CL
Role of Anesthesiology in Global Health. 19 November 2014; DOI:10.1007/978-3-319-09423-6_9
Médecins Sans Frontières/Doctors Without Borders (MSF) has been running surgical programs since the early 1980s. This chapter provides an overview of the anesthesia component of these programs and explores some lessons learned from the experience of one of MSF’s five Operations Centers—in this case, the Belgium-based unit (MSF-Belgium). During the period from 2010 until the end of 2013, these projects provided surgical care to more than 56,000 surgical patients in 23 countries and performed over 73,000 surgical procedures. This experience has shown that surgeons and anesthetists need to discard preconceived notions of an inevitable link between the technical complexity of surgical and anesthesia techniques and the ability to reduce morbidity and mortality. On the contrary, MSF has found that keeping our interventions simple, accessible and sustainable within a given context is often the most effective way to best serve the needs of the many.
Journal Article > CommentaryAbstract
Int J Drug Policy. 18 May 2015; Volume 26 (Issue 11); DOI:10.1016/j.drugpo.2015.05.004
Ford NP, Wiktor SZ, Kaplan K, Andrieux-Meyer I, Hill AM, et al.
Int J Drug Policy. 18 May 2015; Volume 26 (Issue 11); DOI:10.1016/j.drugpo.2015.05.004
Journal Article > ReviewAbstract
Int Orthop. 12 May 2013; Volume 37 (Issue 8); DOI:10.1007/s00264-013-1904-7
Herard P, Boillot F
Int Orthop. 12 May 2013; Volume 37 (Issue 8); DOI:10.1007/s00264-013-1904-7
Journal Article > ReviewAbstract
Lancet. 27 April 2015; Volume 385; DOI:10.1016/S0140-6736(15)60826-1
Sharma DB, Hayman K, Stewart BT, Dominguez LB, Trelles M, et al.
Lancet. 27 April 2015; Volume 385; DOI:10.1016/S0140-6736(15)60826-1
Journal Article > CommentaryAbstract Only
Science. 12 September 2014; Volume 345 (Issue 6202); 1290-1292.; DOI:10.1126/science.1254164
Ager A, Burnham G, Checchi F, Gayer M, Grais RF, et al.
Science. 12 September 2014; Volume 345 (Issue 6202); 1290-1292.; DOI:10.1126/science.1254164
Given the growing scale and complexity of responses to humanitarian crises, it is important to develop a stronger evidence base for health interventions in such contexts. Humanitarian crises present unique challenges to rigorous and effective research, but there are substantial opportunities for scientific advance. Studies need to focus where the translation of evidence from noncrisis scenarios is not viable and on ethical ways of determining what happens in the absence of an intervention. Robust methodologies suited to crisis settings have to be developed and used to assess interventions with potential for delivery at scale. Strengthening research capacity in the low- to middle-income countries that are vulnerable to crises is also crucial.
Journal Article > LetterFull Text
Lancet Global Health. 19 August 2014; Volume 2 (Issue 8); DOI:10.1016/S2214-109X(14)70252-9
Dorlo TPC, Balasegaram M
Lancet Global Health. 19 August 2014; Volume 2 (Issue 8); DOI:10.1016/S2214-109X(14)70252-9
Journal Article > CommentaryFull Text
Public Health Action. 21 September 2012; Volume 2 (Issue 3); DOI:10.5588/pha.12.0022
Bissell K, Harries AD, Reid A, Edginton ME, Hinderaker SG, et al.
Public Health Action. 21 September 2012; Volume 2 (Issue 3); DOI:10.5588/pha.12.0022
Journal Article > CommentaryFull Text
Southern African Journal of HIV medicine. 1 March 2012
Andrieux-Meyer I, Clayden P, Collins S, Geffen N, Goemaere E, et al.
Southern African Journal of HIV medicine. 1 March 2012
Journal Article > CommentaryFull Text
BJOG. 11 June 2013; Volume 120 (Issue 8); DOI:10.1111/1471-0528.12131
Garry RF
BJOG. 11 June 2013; Volume 120 (Issue 8); DOI:10.1111/1471-0528.12131